<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="KO" article-type="research-article">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Korean Assoc Pediatr Surg</journal-id>
<journal-id journal-id-type="publisher-id">JKAPS</journal-id>
<journal-title-group>
<journal-title>Journal of the Korean Association of Pediatric Surgeons</journal-title>
</journal-title-group>
<issn pub-type="ppub">2383-5036</issn>
<publisher>
<publisher-name>Korean Association of Pediatric Surgeons</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.13029/jkaps.2015.21.2.17</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Surgical Treatment of Difficult Cervicofacial Lymphangioma in Children</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Hwang</surname>
<given-names>Deokbi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sanghoon</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Lim</surname>
<given-names>So Young</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Suk-Koo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Seo</surname>
<given-names>Jeong-Meen</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

</contrib-group>

<aff id="A1"><label>1</label>Division of Pediatric Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
<aff id="A2"><label>2</label>Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>

<author-notes>
<corresp>Correspondence: Jeong-Meen Seo. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea. Tel: +82-2-3410-0282, Fax: +82-2-3410-0040, <email>jm0815.seo@samsung.com</email></corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>12</month>
<year>2015</year>
</pub-date>
<volume>21</volume>
<issue>2</issue>
<fpage>17</fpage>
<lpage>23</lpage>

<history>
<date date-type="received">
<day>28</day>
<month>07</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>09</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>10</month>
<year>2015</year>
</date>
</history>

<permissions>
<copyright-statement>Copyright &#x00A9; 2015 by the Korean Association of Pediatric Surgeons</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>

<abstract>
<sec>
<title>Purpose</title>
<p>Cervical lymphangiomas are rare lymphovascular malformations arising in the neck, which form huge fluid-containing cysts. Treatment of the malformation consists of surgery and sclerotherapy. However, the optimal approach is still controversial. Here, we describe a series of cervical lymphangiomas which have been treated with surgical approaches.</p>
</sec>
<sec>
<title>Methods</title>
<p>We retrospectively investigated the medical records of 82 patients who had been diagnosed with cervicofacial lymphangioma from 2001 to 2012 in our center. A closed suction drainage with negative pressure was placed on the operative lesion following excision to prevent reaccumulation of lymphatic fluid and the drainage tube was removed after injecting OK-432 through the tube.</p>
</sec>
<sec>
<title>Results</title>
<p>Twelve patients underwent surgical excision of cervical lymphangioma. The median patient age was 3 months at the time of the operation. The patients have been followed-up over a period of 34 months. When lesions were located near vital organs such as the trachea or carotid artery or did not respond to repetitive OK-432 injections, surgical treatment might bring good outcomes. However, swallowing difficulty, lip palsy, or dyslalia due to adjacent nerve damage temporarily appeared as postoperative complications. Five children had tracheostomy due to tracheal or subglottic stenosis and 2 patients had gastrostomy due to aspiration while they eat after surgery.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Surgery for cervicofacial lymphangioma should be conducted carefully in selective cases. A well thought-out surgical plan with a multidisciplinary surgical team approach and placement of closed suction drainage tube after surgery and adjuvant OK-432 sclerotherapy through drainage tube seem to be helpful for good outcome.</p>
</sec>
</abstract>

<kwd-group>
<kwd>Cervical lymphangioma</kwd>
<kwd>Lymphatic malformation</kwd>
<kwd>OK-432 sclerotherapy</kwd>
<kwd>Excision</kwd>
<kwd>Suction drainage</kwd>
</kwd-group>


</article-meta>
</front>


<back>

<fn-group>
<fn fn-type="conflict">
<label>CONFLICTS OF INTEREST</label>
  <p>No potential conflict of interest relevant to this article was reported.</p>
</fn>
</fn-group>

<ref-list>
  <ref id="B1">
    <label>1</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Poldervaart</surname>
          <given-names>MT</given-names>
        </name>
        <name>
          <surname>Breugem</surname>
          <given-names>CC</given-names>
        </name>
        <name>
          <surname>Speleman</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Pasmans</surname>
          <given-names>S</given-names>
        </name>
      </person-group>
      <article-title>Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature</article-title>
      <source>J Craniofac Surg</source>
      <year>2009</year>
      <volume>20</volume>
      <fpage>1159</fpage>
      <lpage>1162</lpage>
    </element-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <element-citation publication-type="book">
      <person-group person-group-type="author">
        <name>
          <surname>Weiss</surname>
          <given-names>SW</given-names>
        </name>
        <name>
          <surname>Goldblum</surname>
          <given-names>JR</given-names>
        </name>
        <name>
          <surname>Enzinger</surname>
          <given-names>FM</given-names>
        </name>
      </person-group>
      <source>Enzinger and Weiss's soft tissue tumors</source>
      <edition>5th ed</edition>
      <publisher-loc>Philadelphia, PA</publisher-loc>
      <publisher-name>Mosby Elsevier</publisher-name>
      <year>2008</year>
    </element-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Luzzatto</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Midrio</surname>
          <given-names>P</given-names>
        </name>
        <name>
          <surname>Tchaprassian</surname>
          <given-names>Z</given-names>
        </name>
        <name>
          <surname>Guglielmi</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Sclerosing treatment of lymphangiomas with OK-432</article-title>
      <source>Arch Dis Child</source>
      <year>2000</year>
      <volume>82</volume>
      <fpage>316</fpage>
      <lpage>318</lpage>
    </element-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Mitsukawa</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Satoh</surname>
          <given-names>K</given-names>
        </name>
      </person-group>
      <article-title>New treatment for cystic lymphangiomas of the face and neck: cyst wall rupture and cyst aspiration combined with sclerotherapy</article-title>
      <source>J Craniofac Surg</source>
      <year>2012</year>
      <volume>23</volume>
      <fpage>1117</fpage>
      <lpage>1119</lpage>
    </element-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Churchill</surname>
          <given-names>P</given-names>
        </name>
        <name>
          <surname>Otal</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Pemberton</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Ali</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Flageole</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Walton</surname>
          <given-names>JM</given-names>
        </name>
      </person-group>
      <article-title>Sclerotherapy for lymphatic malformations in children: a scoping review</article-title>
      <source>J Pediatr Surg</source>
      <year>2011</year>
      <volume>46</volume>
      <fpage>912</fpage>
      <lpage>922</lpage>
    </element-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Okazaki</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Iwatani</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Yanai</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Kobayashi</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Kato</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Marusasa</surname>
          <given-names>T</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Treatment of lymphangioma in children: our experience of 128 cases</article-title>
      <source>J Pediatr Surg</source>
      <year>2007</year>
      <volume>42</volume>
      <fpage>386</fpage>
      <lpage>389</lpage>
    </element-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Kim</surname>
          <given-names>MG</given-names>
        </name>
        <name>
          <surname>Kim</surname>
          <given-names>SG</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>JH</given-names>
        </name>
        <name>
          <surname>Eun</surname>
          <given-names>YG</given-names>
        </name>
        <name>
          <surname>Yeo</surname>
          <given-names>SG</given-names>
        </name>
      </person-group>
      <article-title>The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts</article-title>
      <source>Laryngoscope</source>
      <year>2008</year>
      <volume>118</volume>
      <fpage>2177</fpage>
      <lpage>2181</lpage>
    </element-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Yoo</surname>
          <given-names>JC</given-names>
        </name>
        <name>
          <surname>Ahn</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Lim</surname>
          <given-names>YS</given-names>
        </name>
        <name>
          <surname>Hah</surname>
          <given-names>JH</given-names>
        </name>
        <name>
          <surname>Kwon</surname>
          <given-names>TK</given-names>
        </name>
        <name>
          <surname>Sung</surname>
          <given-names>MW</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result</article-title>
      <source>Otolaryngol Head Neck Surg</source>
      <year>2009</year>
      <volume>140</volume>
      <fpage>120</fpage>
      <lpage>123</lpage>
    </element-citation>
  </ref>

  <ref id="B9">
    <label>9</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Adams</surname>
          <given-names>MT</given-names>
        </name>
        <name>
          <surname>Saltzman</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Perkins</surname>
          <given-names>JA</given-names>
        </name>
      </person-group>
      <article-title>Head and neck lymphatic malformation treatment: a systematic review</article-title>
      <source>Otolaryngol Head Neck Surg</source>
      <year>2012</year>
      <volume>147</volume>
      <fpage>627</fpage>
      <lpage>639</lpage>
    </element-citation>
  </ref>

  <ref id="B10">
    <label>10</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Kim</surname>
          <given-names>SY</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Seo</surname>
          <given-names>JM</given-names>
        </name>
        <name>
          <surname>Lim</surname>
          <given-names>SY</given-names>
        </name>
      </person-group>
      <article-title>Postoperative adjuvant OK-432 sclerotherapy for treatment of cervicofacial lymphatic malformations: an outcomes comparison</article-title>
      <source>Int J Pediatr Otorhinolaryngol</source>
      <year>2015</year>
      <volume>79</volume>
      <fpage>570</fpage>
      <lpage>575</lpage>
    </element-citation>
  </ref>

  <ref id="B11">
    <label>11</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Chakravarti</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Bhargava</surname>
          <given-names>R</given-names>
        </name>
      </person-group>
      <article-title>Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin</article-title>
      <source>Int J Pediatr Otorhinolaryngol</source>
      <year>2013</year>
      <volume>77</volume>
      <fpage>1367</fpage>
      <lpage>1369</lpage>
    </element-citation>
  </ref>

  <ref id="B12">
    <label>12</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hirose</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Harrison</surname>
          <given-names>MR</given-names>
        </name>
      </person-group>
      <article-title>The ex utero intrapartum treatment (EXIT) procedure</article-title>
      <source>Semin Neonatol</source>
      <year>2003</year>
      <volume>8</volume>
      <fpage>207</fpage>
      <lpage>214</lpage>
    </element-citation>
  </ref>

  <ref id="B13">
    <label>13</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Leva</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Pansini</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Fava</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Maestri</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Pansini</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Selvaggio</surname>
          <given-names>G</given-names>
        </name>
      </person-group>
      <article-title>The role of the surgeon in the case of a giant neck mass in the EXIT procedure</article-title>
      <source>J Pediatr Surg</source>
      <year>2005</year>
      <volume>40</volume>
      <fpage>748</fpage>
      <lpage>750</lpage>
    </element-citation>
  </ref>

  <ref id="B14">
    <label>14</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Stevens</surname>
          <given-names>GH</given-names>
        </name>
        <name>
          <surname>Schoot</surname>
          <given-names>BC</given-names>
        </name>
        <name>
          <surname>Smets</surname>
          <given-names>MJ</given-names>
        </name>
        <name>
          <surname>Kremer</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Manni</surname>
          <given-names>JJ</given-names>
        </name>
        <name>
          <surname>Gavilanes</surname>
          <given-names>AW</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>The ex utero intrapartum treatment (EXIT) procedure in fetal neck masses: a case report and review of the literature</article-title>
      <source>Eur J Obstet Gynecol Reprod Biol</source>
      <year>2002</year>
      <volume>100</volume>
      <fpage>246</fpage>
      <lpage>250</lpage>
    </element-citation>
  </ref>
</ref-list>

</back>

<floats-group>

<fig position="float" id="F1">
<label>Fig. 1</label>
<caption>
  <p>(A) Patient No. 2 was diagnosed with cervical lymphangioma prenatally by fetal MRI. (B) The patient was about to have a surgery 18 days after birth through EXIT procedure. (C) This picture was taken 1 year and 8 months after surgery. EXIT, ex utero intrapartum treatment.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-g001"></graphic>
</fig>

<fig position="float" id="F2">
<label>Fig. 2</label>
<caption>
  <p>(A) Patient No. 4 was transferred to our hospital after OK-432 sclerotherapy. (B) This patient had a surgery about lymphangioma involving from right temporal area to neck. (C) This photograph was taken 9 months after surgery and a subsequent sclerotherapy.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-g002"></graphic>
</fig>

<fig position="float" id="F3">
<label>Fig. 3</label>
<caption>
  <p>(A) Patient No. 6 visited our hospital after having gotten several times of sclerotherapies using OK-432 and ethanol. (B) This photograph was taken 3 years after surgery.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-g003"></graphic>
</fig>

<fig position="float" id="F4">
<label>Fig. 4</label>
<caption>
  <p>(A) MRI shows macrocystic lymphatic malformations which are involving from right neck to axilla before OK-432 sclerotherapy (patient No. 9). (B) Intralesional hemorrhage happened one month after sclerotherapy.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-g004"></graphic>
</fig>

<fig position="float" id="F5">
<label>Fig. 5</label>
<caption>
  <p>(A) Sagittal T2-weighted MRI shows cervical lymphangioma which are infiltrating tongue base (patient No. 11). (B) Decreased lymphatic malformation after surgery.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-g005"></graphic>
</fig>

<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption>
  <p>Preoperative Characteristics of 12 Patients with Cervical Lymphangioma and perioperative Details</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-i001"></graphic>
<table-wrap-foot>
<fn>
  <p>POD, postoperative day; EXIT, ex utero intrapartum treatment; RFA, radiofrequency ablation.</p>
  <p><sup>a)</sup>Median 300 min, range 59-559 min. <sup>b)</sup>Mean 19 days, range 7-46 days.</p>
</fn>
</table-wrap-foot>
</table-wrap>

<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption>
  <p>Distribution of Our Patients according to the Anatomic Location of Lymphangiomas</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkaps-21-17-i002"></graphic>
</table-wrap>

</floats-group>

</article>